| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | L01XX53 |
| UNII: | K6A90IIZ19 |
| InChI Key | XZAFZXJXZHRNAQ-STQMWFEESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H19N5O4S |
| Molecular Weight | 401.45 |
| AlogP | 0.96 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 109.58 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | DNA inhibitor | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Myeloid, Acute | 3 | D015470 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 175414-77-4 |
| ChEMBL | CHEMBL68117 |
| DrugBank | DB11999 |
| FDA SRS | K6A90IIZ19 |
| PubChem | 9952884 |
| SureChEMBL | SCHEMBL674441 |
| ZINC | ZINC000026186622 |